×

What are you searching for?




Pharmaceuticals

4 Min read

COVID-19 VACCINE: HUMAN TRIALS OF COVAXIN BEGIN TODAY AT AIIMS DELHI

Published On 20 Jul 2020 11:26 AM


SHARE THIS ARTICLE  


Highlights

• People ageing between 18 and 55 and with no comorbidities are eligible to volunteer for the clinical trials of COVAXIN

• COVAXIN developed by Hyderabad-based Bharat Biotech along with the ICMR and the NIV were the first to receive an approval from the DCGI to conduct human trials

• AIIMS Delhi has started enrolling the volunteers and their screening before 

Human trials f....


Tags : COVAXIN, Bharat Biotech, AIIMS Delhi, ICMR, NIV, COVID-19 vaccine,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)